When blood fat levels rise, fats start accumulating in the vessel walls, causing the vessels to become rigid. Over time, these vessels can get blocked, increasing the risk of stroke, heart attack, and angina pectoris.

While we can manage our blood fat levels by adopting healthier habits – such as maintaining a balanced diet, engaging in regular exercise, moderating alcohol intake, and refraining from smoking – these measures might not suffice for extremely high blood fat levels. Some conditions that disrupt lipid regulation in the body necessitate both lifestyle changes and medicinal intervention. These conditions, termed lipid disorders, manifest as elevated blood lipid levels or imbalances between various blood lipids.

There's a wide spectrum of diseases associated with blood lipid disorders. This ranges from rare genetic conditions like familial chylomicronemia (FCS) and lipodystrophy, which impact only a few thousand people globally, to more prevalent conditions affecting millions, including dyslipidemia, severe hypertriglyceridemia (SHTG), cardiovascular disease, type 2 diabetes, and fatty liver.

Lipigon, in its initiatives, targets these diverse blood lipid disorders to pioneer new treatments.